October 29, 2025 — UNISONS, a leading Chinese probiotic enterprise, presented its flagship product **Unisons® AMY001 AKK bacteria** at SSG 2025.
This exhibition marks a key step for UNISONS in going global after expanding into the European and Asian markets, and also demonstrates the technological confidence of Chinese enterprises in leading the international discourse of the probiotic industry.
SSG: The Global "Bellwether" for Health Ingredients
SupplySide Global (SSG), the world’s premier exhibition for natural, health and innovative ingredients, is held every
October. It brings together over 1,300 global exhibitors and more than 80,000 professional buyers, covering functional
foods, dietary supplements and other sectors, serving as a core platform for innovation display and business
cooperation. UNISONS made its debut with Unisons® dual matrix of "core strains + patented formulations": It highlighted
**Unisons AMY001 AKK** and its allergen-free probiotic ingredient series, while also showcasing
its proprietary patented strains and a product matrix covering ten major functional categories, demonstrating its
full-scenario service capabilities.
Technical Breakthrough: Overcoming Industrialization Challenges of AKK
Unisons® AKK bacteria with full-chain technological breakthroughs has become a core highlight at the exhibition.
After five years of dedicated R&D, the company has achieved an industrialization technological breakthrough for the AKK strain and established a stable and controllable supply chain system, successfully overcoming three major industry bottlenecks in one go:
- Strain Screening and Cultivation Optimization: Unisons® AMY001 AKK was precisely isolated and screened from the intestinal tract of healthy humans. The AKK raw material produced from this strain has been verified by authoritative gene sequencing, with a strain purity of up to 99.84%, strictly meeting the "zero contaminating bacteria" standard. This strain has obtained the U.S. GRAS safety application qualification and has clear efficacy in fields such as intestinal barrier repair, scientific weight management, and precise regulation of blood glucose and blood lipids.
- Innovation in Anaerobic Culture Technology:After hundreds of process iterations and optimizations, we have successfully overcome the industry pain point of high-density anaerobic fermentation of Akkermansia muciniphila (AKK bacteria).We have now achieved a stable annual production capacity of 100 tons of AKK bacteria, reducing production costs by 80% compared with traditional industrial processes.Coupled with high-fidelity inactivation technology, the retention rate of key functional proteins reaches a top industry level, and the shelf life of products at room temperature is extended to more than 18 months, far exceeding the industry average standard of 12 months.
In response to the high prevalence of allergies in the European and American markets, based on the "zero-pollution" foundation of the "012 Golden Standard", UNISONS has developed a zero-allergen series of probiotic raw materials.
The product controls risks from the source: common allergenic ingredients such as dairy products and gluten are eliminated at the raw material stage, and a dedicated hypoallergenic fermentation medium is adopted.
It is planned to prioritize covering star strains including AKK bacteria and Bb-12, which has attracted key inquiries from North American brands on-site.
Capacity Support: Building a "Moat" for Quality Assurance
UNISONS: Core Competitiveness Built on "Smart Manufacturing + Strict Quality Control"
UNISONS has established an irreplicable core competitiveness through smart manufacturing and stringent quality control, with three prominent advantages:
•
Smart Capacity Layout
Relying on a 100,000 ㎡ intelligent production base in Ningbo (52,000 ㎡ core production area), equipped with Class 10,000 clean workshops and automated production lines complying with the international authoritative EHEDG standards.
It achieves a global supply chain response efficiency of 30-day order delivery, truly fulfilling the goal of "One factory serving the globe".
•
Innovative Quality Standard System
Independently created and implemented the "012 Golden Standard", setting a new benchmark for quality in the probiotic industry and reshaping raw material specifications:
- 0 contamination by miscellaneous bacteria
- Grade 1 bacterial powder quality
- 2nd-generation functional probiotics
• Whole Industry Chain Control
A closed-loop quality control system covering the entire process:
Strain Resource Bank → Fermentation & Culture → Freeze-drying & Purification → Packaging & Logistics.
Supported by an exclusive customized pharmaceutical-grade intelligent production line and a full product lifecycle traceability system, it realizes standardized and visual management from raw materials to finished products.
SSG 2025 Successfully Concluded
UNISONS at SSG 2025
UNISONS’ appearance at SSG 2025 marked not only the North American debut of its industrialized AKK bacteria technology, but also a significant milestone for China’s probiotic industry in competing on the international stage.
Going forward, backed by continuous technological innovation, world-leading production capacity and quality control systems, the company will further deepen its presence in the global market.
Under the UNISONS® brand, it will deliver "Made in China & Intelligent Manufacturing" solutions, driving China’s innovation from industry benchmark to global leadership.
With the successful conclusion of the exhibition, UNISONS® welcomes customers from around the world to visit and look forward to meeting you again!
